Navigation Links
Pfizer to Present More Than 40 Abstracts on Pre-Clinical, Clinical and Outcomes Research at Alzheimer's Association International Conference on Alzheimer's Disease
Date:7/8/2010

ties.  As AD progresses, individuals may also experience changes in personality and behavior, such as anxiety, agitation, delusions or hallucinations. AD and other dementias currently affect an estimated 35.6 million people worldwide, a number that is expected to double every 20 years, to 65.7 million in 2030.(1)  In the United States alone, the disease is so prevalent that every 70 seconds someone is diagnosed with AD.(2)  AD not only places a tremendous burden on patients, but also on those caring for them, and global healthcare systems.  The total worldwide societal cost for AD and other dementias is estimated at $422 billion in 2009, with U.S. specific costs estimated at $97 billion.(3)

Pfizer Inc.: Working together for a healthier world™

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life.  We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known consumer products.  Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.  Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world.  For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more about our commitments, please visit us at

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013  This year alone, The ... 300 research projects with one goal in mind: Discovering ... "Team In Training" (TNT), a flagship LLS fundraising campaign ... program, is marking its landmark 25 th anniversary. ... $875 million in research to discover and deliver breakthrough ...
(Date:6/19/2013)... , June 19, 2013 Today MedeAnalytics, ... introduced the next-generation of its Employer Group ... health plans to provide their employer groups an ... factors, medical and prescription drug claims, network utilization, ... http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) "Employer Group ...
(Date:6/18/2013)... MILAN , June 19, 2013 ... in fluctuating Parkinson,s disease (PD) patients as add-on ... clinically important improvement in motor symptoms in fluctuating ...   Newron Pharmaceuticals S.p.A. ("Newron"), a ... and pain therapies, and its partner Zambon S.p.A., ...
Breaking Medicine Technology:Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 2Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 3Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 4Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 5MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6
... 2011 Asante Solutions, Inc. (Asante), a medical device ... the CE mark for its Pearl Insulin Pump, the ... The CE mark is a European proof of conformity ... environmental requirements. Asante has begun discussions with potential distribution ...
... 12, 2011 PRA International, a leading Clinical Research Organization, ... (SRM) group will speak at the World Drug Safety Congress ... will also host an exhibit at booth #2. ... chair the first breakout stream, "Operational Safety," on 13 April ...
Cached Medicine Technology:Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump 2PRA International Experts to Speak at Drug Safety Conference 2
(Date:6/19/2013)... years, Alzheimer,s researchers have focused on two proteins that ... may contribute to the disease: plaques made up of ... tau. , But for the first time, an Alzheimer,s ... independently, but at the interaction of the two proteins ... post-mortem Alzheimer,s patients and in mouse brains with Alzheimer,s ...
(Date:6/19/2013)... that the incidence of cancer is many fold higher ... have an inadequate understanding on how best to treat ... are occasionally included in clinical trials, those elderly patients ... patients. Thus, the broader elderly patient population is not ... the Elderly Task Force is now starting a new ...
(Date:6/19/2013)... IL (PRWEB) June 19, 2013 Chicago is ... the 31st, 48th and 50th Chicago Wards will require landlords ... – or face fines. The ordinance also makes ... complying with all treatment requests – which often include disposing ... pest control company Orkin reported that it did more bed ...
(Date:6/19/2013)... The Cancer Support Community (CSC), an international nonprofit organization, ... whole patient with the launch today of the Cancer ... event, held at the Newseum, will feature a keynote ... members who have made a significant impact on cancer ... engaged in the cancer journey. , ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 A brain ... for those closest to them. The sudden onset of ... brain tumor has on a patient’s behavioral and cognitive ... both the patient and family. The American Brain ... July 26 and Saturday, July 27 in Chicago, focuses ...
Breaking Medicine News(10 mins):Health News:New Alzheimer's research suggests possible cause: The interaction of proteins in the brain 2Health News:EORTC study opens for elderly patients with HER-2 positive metastatic breast cancer 2Health News:Chicago Ordinance Requires Landlords and Tenants to Take Responsibility for Bed Bugs 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 3Health News:American Brain Tumor Association Conference Advances Holistic Approach to Living with a Brain Tumor 2Health News:American Brain Tumor Association Conference Advances Holistic Approach to Living with a Brain Tumor 3
... 2, 2010 As part of a national clinical ... in effectiveness between two popular treatments for one of ... incontinence. Stress incontinence affects up to 50 percent ... their lives. Women with stress incontinence experience leakage during ...
... PeriGen, ... clinical and financial value, today announced that Donald A. Deieso, Ph.D., the Company’s Chairman ... 2010 Award in New Jersey. , ... Princeton, NJ -- PeriGen, Inc. , the only OB-specific risk ...
... has received the human papillomavirus (HPV) vaccine to help prevent ... Washington University School of Medicine in St. Louis. The ... American Journal of Preventive Medicine . The HPV vaccine ... of which are found in about 70 percent of all ...
... Healthcare reform -- and the many options for fixing a broken ... According to an article in the June issue of the ... many who suffer from disabling arthritis of the hip and knee, ... crisis to medical care. "This is not a just a ...
... if young adults were more fit, 34% of high blood ... News) -- Low levels of physical activity and fitness significantly ... study of young adults shows. , The study, released online ... issue of the journal Hypertension , found that about ...
... have paired up to create technology that has ... the first procedure-based, hands-on surgical training software. Their ... surgeons through real-time operative procedures using the Robotic ... MD, a staff physician in Urology at Roswell ...
Cached Medicine News:Health News:UT Southwestern investigators perform head-to-head comparison of incontinence treatments 2Health News:Donald A. Deieso, Ph.D., Chairman & CEO, PeriGen, Inc. Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist 2Health News:Donald A. Deieso, Ph.D., Chairman & CEO, PeriGen, Inc. Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist 3Health News:One-third of young girls get HPV vaccine to prevent cervical cancer 2Health News:One-third of young girls get HPV vaccine to prevent cervical cancer 3Health News:Health-care economics and policy: It's a perfect storm 2Health News:Health-care economics and policy: It's a perfect storm 3Health News:Being Young and Sedentary Raises Hypertension Risk Later 2Health News:Being Young and Sedentary Raises Hypertension Risk Later 3Health News:Surgeon-engineer team produce training software for robot-assisted surgery 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: